Blackmores

Blackmores, a Pharmaceutical Preparation Manufacturing company headquartered in Australia, reported total carbon emissions of approximately 2,200,000 kg CO2e for 2023. This total includes Scope 1 emissions of approximately 350,000 kg CO2e, Scope 2 emissions of about 900,000 kg CO2e, and Scope 3 emissions of approximately 550,000 kg CO2e.

Looking back, Blackmores reported total emissions of approximately 1,655,000 kg CO2e in 2022, with Scope 1 emissions at approximately 300,000 kg CO2e, Scope 2 at about 855,000 kg CO2e, and Scope 3 at around 500,000 kg CO2e. For 2021, the company's total emissions were approximately 13,522,000 kg CO2e, primarily from Scope 2 emissions of about 8,799,000 kg CO2e. In 2020, total emissions were approximately 13,684,000 kg CO2e, with Scope 2 contributing around 8,929,000 kg CO2e. In 2019, total emissions stood at approximately 8,339,000 kg CO2e, including Scope 2 emissions of about 4,859,000 kg CO2e.

Further historical data reveals that in 2018, Blackmores' Scope 1 emissions were approximately 587,000 kg CO2e, Scope 2 emissions were about 4,754,000 kg CO2e, and Scope 3 emissions were around 3,160,000 kg CO2e. In 2017, the company recorded Scope 1 emissions of approximately 670,000 kg CO2e, Scope 2 emissions of about 4,896,000 kg CO2e, and Scope 3 emissions of around 3,466,000 kg CO2e. For 2016, total emissions were approximately 9,245,000 kg CO2e, encompassing Scope 1 emissions of about 639,000 kg CO2e, Scope 2 emissions of around 5,382,000 kg CO2e, and Scope 3 emissions of approximately 3,224,000 kg CO2e.

Blackmores is a current subsidiary of Kirin Holdings Company, Limited, and as such, some of its climate initiatives, including SBTi reduction targets, RE100 commitments, and RTZ commitments, are cascaded from Kirin Holdings Company, Limited. However, Blackmores Limited is the source organization for its CDP disclosures and overall organizational performance data.